List of insiders holdings for Inhibikase Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Sands Capital Life Sciences Pulse Fund II L.P. Sands Capital Ventures LLC SANDS FRANK M. 10% Owner | 2024-10-25 17:52:18 | 10,950,000 0 | 10,950,000 | Form 3 |
| Kalman Daniel 10% Owner | 2021-03-23 13:32:52 | 1,748,312 0 | 1,748,312 | Form 13G |
| Bellini Roberto Director | 2024-10-23 19:53:27 | 60,000 1,460,000 | 1,520,000 | Form 4 |
| Munshi Amit Director | 2024-10-23 19:43:35 | 60,000 365,000 | 425,000 | Form 4 |
| Kush Arvind Director | 2024-10-23 19:49:49 | 205,000 0 | 205,000 | Form 4 |
| FRATTAROLI JOSEPH Cheif Financial Officer | 2023-03-03 17:00:29 | 138,091 0 | 138,091 | Form 4 |
| Lees-Rolfe Garth Chief Financial Officer | 2024-04-02 17:14:33 | 90,000 0 | 90,000 | Form 4 |
| Canner David Director | 2024-10-23 19:58:15 | 60,000 0 | 60,000 | Form 4 |
| Werner Milton H. President and CEO 10% Owner | 2024-04-03 16:47:23 | 45,000 0 | 45,000 | Form 4 |
| O'Farrell Elizabeth G. Director | 2022-06-28 21:00:26 | 40,000 0 | 40,000 | Form 4 |
| Freeman Roy Lester Director | 2024-07-18 17:18:33 | 30,000 0 | 30,000 | Form 4 |
| BERMAN DENNIS N Director | 2024-07-18 17:20:28 | 0 30,000 | 30,000 | Form 4 |
| Dion Gisele Director | 2024-07-18 17:23:53 | 30,000 0 | 30,000 | Form 4 |
| GRINT PAUL C Director | 2024-07-18 17:27:33 | 30,000 0 | 30,000 | Form 4 |